首页 正文

Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer

{{output}}
Small cell lung cancer (SCLC) is a very aggressive cancer with poor outcome if left untreated, but it is also one of the most chemotherapy responsive cancers. Overall it has a very poor prognosis especially if it is chemotherapy resistant to first line treatme... ...